Related references
Note: Only part of the references are listed.Differences in longitudinal associations of cardiovascular risk factors with arterial stiffness and pressure wave reflection in middle-aged Japanese men
Masatsune Fujii et al.
HYPERTENSION RESEARCH (2021)
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Francesco Cosentino et al.
EUROPEAN HEART JOURNAL (2020)
Impact of hypertension stratified by diabetes on the lifetime risk of cardiovascular disease mortality in Japan: a pooled analysis of data from the Evidence for Cardiovascular Prevention from Observational Cohorts in Japan study
Yukiko Imai et al.
HYPERTENSION RESEARCH (2020)
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
Donna K. Arnett et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)
Satoshi Umemura et al.
HYPERTENSION RESEARCH (2019)
Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Peter W. F. Wilson et al.
CIRCULATION (2019)
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Paul K. Whelton et al.
HYPERTENSION (2018)
Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms
John R. Petrie et al.
CANADIAN JOURNAL OF CARDIOLOGY (2018)
Heart rate as a predictor of cardiovascular risk
Marijana Tadic et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2018)
2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams et al.
EUROPEAN HEART JOURNAL (2018)
Response to Comment on Itoh et al. Intensive Treat-to-Target Statin Therapy in High-Risk Japanese Patients With Hypercholesterolemia and Diabetic Retinopathy: Report of a Randomized Study. Diabetes Care 2018;41:1275-1284
Hiroshi Itoh et al.
DIABETES CARE (2018)
Clinician's Guide to Reducing Inflammation to Reduce Atherothrombotic Risk JACC Review Topic of the Week
Paul M. Ridker
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Synergistic effects of blood pressure-lowering drugs and statins: systematic review and meta-analysis
Johan Sundstrom et al.
BMJ EVIDENCE-BASED MEDICINE (2018)
Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome
Fosca Quarti Trevano et al.
JOURNAL OF HYPERTENSION (2017)
Primary Prevention of Cardiovascular Disease in Diabetes Mellitus
Jonathan D. Newman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Combining Potent Statin Therapy with Other Drugs to Optimize Simultaneous Cardiovascular and Metabolic Benefits while Minimizing Adverse Events
Kwang Kon Koh et al.
KOREAN CIRCULATION JOURNAL (2017)
Pleiotropic Effects of Statins on the Cardiovascular System
Adam Oesterle et al.
CIRCULATION RESEARCH (2017)
Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study
Jack R. W. Brownrigg et al.
LANCET DIABETES & ENDOCRINOLOGY (2016)
The effect of statins on sympathetic activity: a meta-analysis
Jacek Lewandowski et al.
CLINICAL AUTONOMIC RESEARCH (2015)
Lowering blood pressure in diabetes
Seema Kang
LANCET DIABETES & ENDOCRINOLOGY (2015)
Blood Pressure Lowering in Type 2 Diabetes A Systematic Review and Meta-analysis
Connor A. Emdin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Statins and the autonomic nervous system
Philip J. Millar et al.
CLINICAL SCIENCE (2014)
Predicting Coronary Heart Disease Using Risk Factor Categories for a Japanese Urban Population, and Comparison with the Framingham Risk Score: The Suita Study
Kunihiro Nishimura et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2014)
Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Colin R. Dormuth et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Vascular stiffness and endothelial dysfunction: Correlations at different levels of blood pressure
Valeria Nasser Figueiredo et al.
BLOOD PRESSURE (2012)
Total Cardiovascular Risk, Blood Pressure Variability and Adrenergic Overdrive in Hypertension: Evidence, Mechanisms and Clinical Implications
Guido Grassi et al.
CURRENT HYPERTENSION REPORTS (2012)
Heart failure as an autonomic nervous system dysfunction
Takuya Kishi
JOURNAL OF CARDIOLOGY (2012)
Cardiovascular Outcomes in Framingham Participants With Diabetes The Importance of Blood Pressure
Guanmin Chen et al.
HYPERTENSION (2011)
Associations of impaired glucose metabolism and dyslipidemia with cardiovascular diseases: what have we learned from Japanese cohort studies for individualized prevention and treatment?
Yoshihiro Kokubo
EPMA JOURNAL (2011)
Calcium channel regulation in vascular smooth muscle cells: Synergistic effects of statins and calcium channel blockers
Gerard F. Clunn et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2010)
Primary Prevention of Cardiovascular Mortality and Events With Statin Treatments
Edward J. Mills et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis
LANCET (2008)
Potential synergy between lipid-lowering and blood-pressure-lowering in the Anglo-Scandinavian Cardiac Outcomes Trial
Peter Sever et al.
EUROPEAN HEART JOURNAL (2006)
Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease - Randomized and observational comparisons of secondary prevention trials and their meta-analyses
CH Hennekens et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Meta-analysis: Glycosylated hemoglobin and cardiovascular disease in diabetes mellitus
E Selvin et al.
ANNALS OF INTERNAL MEDICINE (2004)
Effects of HMG-CoA reductase inhibitors on endothelial function - Role of microdomains and oxidative stress
RP Mason et al.
CIRCULATION (2004)
Fluvastatin enhances the inhibitory effects of a selective angiotensin II type 1 receptor blocker, valsartan, on vascular neointimal formation
M Horiuchi et al.
CIRCULATION (2003)
Share Paper
